Methylenedioxymethamphetamine (ecstasy) decreases neutrophil activity and alters leukocyte distribution in bone marrow, spleen and blood

NeuroImmunoModulation

Volumn 16, Issue 3, 2009, Pages 191-200

  Ferraz De Paula, Viviane ^a   Ribeiro, Alison ^a   Pinheiro, Milena L ^a   Sakai, Mônica ^a   Lacava, Mariana C R ^b   Lapachinske, Silvio F ^b   Moreau, Regina L M ^b   Palermo Neto, João ^a,c  

^a Section of Domestic and Wild Animals Anatomy   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Cidade Universitaria   (Brazil)

Author keywords

Corticosterone; Leukocyte traffic; Methylenedioxymethamphetamine; Neutrophil; Oxidative burst; Phagocytosis

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CORTICOSTERONE; NORADRENALIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; BONE MARROW; CELL VIABILITY; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; LEUKOCYTE; MALE; MOUSE; NEUTROPHIL; NONHUMAN; NORADRENERGIC SYSTEM; PHAGOCYTOSIS; PRIORITY JOURNAL; RESPIRATORY BURST; SPLEEN;

EID: 60749134994     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000204233     Document Type: Article

References (84)

1. Selye H: A syndrome produced by diverse nocuous agents (1936). J Neuropsychiatry Clin Neurosci 1998;10:230-231.
2. Besedovsky H, Sorkin E, Felix D, Haas H: Hypothalamic changes during the immune response. Eur J Immunol 1977;7:323-325.
3. Domingues-Junior M, Pinheiro SR, Guerra JL, Palermo-Neto J: Effects of treatment with amphetamine and diazepam on Mycobacterium bovis-induced infection in hamsters. Immunopharmacol Immunotoxicol 2000;22:555-574.
4. Righi DA, Pinheiro SR, Guerra JL, Palermo-Neto J: Effects of diazepam on Mycobacterium bovis-induced infection in hamsters. Braz J Med Biol Res 1999;32:1145-1153.
5. Lazzarini R, Malucelli BE, Palermo-Neto J: Reduction of acute inflammation in rats by diazepam: role of peripheral benzodiazepine receptors and corticosterone. Immunopharmacol Immunotoxicol 2001;23:253-265.
6. Lazzarini R, Malucelli BE, Muscará MN, De Nucci G, Palermo-Neto J: Reduction of inflammation in rats by diazepam: tolerance development. Life Sci 2003;72:2361-2368.
7. Lazzarini R, Maiorka PC, Liu J, Papadopoulos V, Palermo-Neto J: Diazepam effects on carrageenan-induced inflammatory paw edema in rats: role of nitric oxide. Life Sci 2006;78:3027-3034.
8. Ligeiro-Oliveira AP, Fialho de Araújo AM, Lazzarini R, Silva ZL, De Nucci G, Muscará MN, Tavares de Lima W, Palermo-Neto J: Effects of amphetamine on immune-mediated lung inflammatory response in rats. Neuroimmunomodulation 2004;11:181-190.
9. Ligeiro de Oliveira AP, Lazzarini R, Cavriani G, Quinteiro-Filho WM, Tavares de Lima W, Palermo-Neto J: Effects of single or repeated amphetamine treatment and withdrawal on lung allergic inflammation in rats. Int Immunopharmacol 2008;8:1164-1171.
10. Stankevicius D, Rodrigues-Costa EC, Camilo Flório J, Palermo-Neto J: Neuroendocrine, behavioral and macrophage activity changes induced by picrotoxin effects in mice. Neuropharmacology 2007;54:300-308.
11. Connor TJ: Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system. Immunology 2004;111:357-367.
12. Pacifici R, Zuccaro P, Farré M, Poudevida S, Abanades S, Pichini S, Langohr K, Segura J, de la Torre R: Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans. Addiction 2007;102:931-936.
13. Pacifici R, Pichini S, Zuccaro P, Farré M, Segura M, Ortuño J, Di Carlo S, Bacosi A, Roset PN, Segura J, de la Torre R: Paroxetine inhibits acute effects of 3,4-methylenedioxymethamphetamine on the immune system in humans. J Pharmacol Exp Ther 2004;309:285-292.
14. Pacifici R, Zuccaro P, Farré M, Pichini S, Di Carlo S, Roset PN, Palmi I, Ortuño J, Menoyo E, Segura J, de la Torre R: Cell-mediated immune response in MDMA users after repeated dose administration: studies in controlled versus noncontrolled settings. Ann NY Acad Sci 2002;965:421-433.
15. Pacifici R, Zuccaro P, Farré M, Pichini S, Di Carlo S, Roset PN, Ortuño J, Pujadas M, Bacosi A, Menoyo E, Segura J, de la Torre R: Effects of repeated doses of MDMA ('ecstasy') on cell-mediated immune response in humans. Life Sci 2001;69:2931-2941.
16. Pacifici R, Zuccaro P, Hernandez López C, Pichini S, Di Carlo S, Farré M, Roset PN, Ortuño J, Segura J, Torre RL: Acute effects of 3,4-methylenedioxymethamphetamine alone and in combination with ethanol on the immune system in humans. J Pharmacol Exp Ther 2001;296:207-215.
17. Pacifici R, Zuccaro P, Farré M, Pichini S, Di Carlo S, Roset PN, Lopez CH, Ortuño J, Segura J, Camí J, de la Torre R: Immunomodulating activity of MDMA. Ann NY Acad Sci 2000;914:215-224.
18. Cabral GA, Dove Pettit DA: Drugs and immunity: cannabinoids and their role in decreased resistance to infectious disease. J Neuroimmunol 1998;83:116-123.
19. Gavrilin MA, Mathes LE, Podell M: Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes. J Neurovirol 2002;8:240-249.
20. Risdahl JM, Khanna KV, Peterson PK, Molitor TW: Opiates and infection. J Neuroimmunol 1998;83:4-18.
21. Friedman H, Newton C, Klein TW: Microbial infections, immunomodulation, and drugs of abuse. Clin Microbiol Rev 2003;16:209-219.
22. Klein TW, Friedman H, Specter S: Marijuana, immunity and infection. J Neuroimmunol 1998;83:102-115.
23. Mellon RD, Bayer BM: Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action. J Neuroimmunol 1998;83:19-28.
24. Núñez-Iglesias MJ, Castro-Bolaño C, Losada C, Pereiro-Raposo MD, Riveiro P, Sánchez-Sebio P, Mayán-Santos JM, Rey-Méndez M, Freire-Garabal M: Effects of amphetamine on cell mediated immune response in mice. Life Sci 1996;58:29-33.
25. Pellegrino T, Bayer BM: In vivo effects of cocaine on immune cell function. J Neuroimmunol 1998;83:139-147.
26. Yu Q, Zhang D, Walston M, Zhang J, Liu Y, Watson RR: Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice. Int Immunopharmacol 2002;2:951-962.
27. Zwick OM, Fischer DH, Flanagan JC: 'Ecstasy' induced immunosuppression and herpes zoster ophthalmicus. Br J Ophthalmol 2005;89:923-924.
28. Indart Pérez A, Mendia Gorostidi A, Barrio Andrés J, Arens Miravé I: Acute hepatitis induced by Ecstasy. Gastroenterol Hepatol 1998;21:499.
29. Connor TJ, Kelly JP, McGee M, Leonard BE: Methylenedioxymethamphetamine (MDMA; Ecstasy) suppresses IL-1β and TNF-α secretion following an in vivo lipopolysaccharide challenge. Life Sci 2000;67:1601-1612.
30. Connor TJ, Dennedy MC, Harkin A, Kelly JP: Methylenedioxymethamphetamine- induced suppression of interleukin-1β and tumour necrosis factor-α is not mediated by serotonin. Eur J Pharmacol 2001;418:147-152.
31. Connor TJ, Harkin A, Kelly JP: Methylenedioxymethamphetamine suppresses production of the proinflammatory cytokine tumor necrosis factor-α independent of a β-adrenoceptor-mediated increase in interleukin-10. J Pharmacol Exp Ther 2005;312:134-143.
32. Boyle NT, Connor TJ: MDMA ('Ecstasy') suppresses the innate IFN-γ response in vivo: a critical role for the anti-inflammatory cytokine IL-10. Eur J Pharmacol 2007;572:228-238.
33. Pacifici R, Zuccaro P, Farré M, Pichini S, Di Carlo S, Roset PN, Ortuño J, Segura J, de la Torre R: Immunomodulating properties of MDMA alone and in combination with alcohol: a pilot study. Life Sci 1999;65:309-316.
34. Glavin GB, Tanaka M, Tsuda A, Kohno Y, Hoaki Y, Nagasaki N: Regional rat brain noradrenaline turnover in response to restraint stress. Pharmacol Biochem Behav 1983;19:287-290.
35. Paré WP, Glavin GB: Animals models of stress in pharmacology; in Van Haaren (ed): Methods in Behavioral Pharmacology. Amsterdam, Elsevier, 1993, pp 413-441.
36. Tanaka M, Kohno Y, Nakagawa R, Ida Y, Takeda S, Nagasaki N: Time-related differences in noradrenaline turnover in rat brain regions by stress. Pharmacol Biochem Behav 1982;16:315-319.
37. Iimori K, Tanaka M, Kohno Y, Ida Y, Nakagawa R, Hoaki Y, Tsuda A, Nagasaki N: Psychological stress enhances noradrenaline turnover in specific brain regions in rats. Pharmacol Biochem Behav 1982;16:637-640.
38. de la Torre R, Farré M, Roset PN, Pizarro N, Abanades S, Segura M, Segura J, Camí J: Human pharmacology of MDMA: pharmacokinetics, metabolism, and disposition. Ther Drug Monit 2004;26:137-144.
39. Segura M, Ortuño J, Farré M, McLure JA, Pujadas M, Pizarro N, Llebaria A, Joglar J, Roset PN, Segura J, de La Torre R:3,4- Dihydroxymethamphetamine (HHMA). A major in vivo 3,4- methylenedioxymethamphetamine (MDMA) metabolite in humans. Chem Res Toxicol 2001;14:1203-1218.
40. Bowyer JF, Young JF, Slikker W, Itzak Y, Mayorga AJ, Newport GD, Ali SF, Frederick DL, Paule MG: Plasma levels of parent compound and metabolites after doses of either D -fenfluramine or D -3,4-methylenedioxymethamphetamine (MDMA) that produce long-term serotonergic alterations. Neurotoxicology 2003;24:379-390.
41. de la Torre R, Farré M: Neurotoxicity of MDMA (ecstasy): the limitations of scaling from animals to humans. Trends Pharmacol Sci 2004;25:505-508.
42. Lacava MCR, Ferraz de Paula V, Lapachinske SF, Palermo-Neto J, Moreau RLM: Simultaneous determination of methylenodioxymethamphetamine (MDMA) and methylenodioxyamphetamine (MDA) in plasma by gas chromatography with nitrogen-phosphorus detection (GC-NPD) and in vitro effects on the neutrophil activity of mice; in III Encuentro Regional de Toxicologia Forense. Bogotá, TIAFT, 2007, pp 97-104.
43. Felicio LF, Florio JC, Sider LH, Cruz-Casallas PE, Bridges RS: Reproductive experience increases striatal and hypothalamic dopamine levels in pregnant rats. Brain Res Bull 1996;40:253-256.
44. Sutanto W, De Kloet ER: Species-specificity of corticosteroid receptors in hamster and rat brains. Endocrinology 1987;121:1405-1411.
45. Sutanto W, van Eekelen JA, Reul JM, de Kloet ER: Species-specific topography of corticosteroid receptor types in rat and hamster brain. Neuroendocrinology 1988;47:398-404.
46. Albers HE, Yogev L, Todd RB, Goldman BD: Adrenal corticoids in hamsters: role in circadian timing. Am J Physiol 1985;248:434-438.
47. Massoco C, Palermo-Neto J: Effects of midazolam on equine innate immune response: a flow cytometric study. Vet Immunol Immunopathol 2003;95:11-19.
48. Hasui M, Hirabayashi Y, Kobayashi Y: Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood. J Immunol Methods 1989;117:53-58.
49. Abercrombie ED, Keefe A, Difrishchia D, Zigmond MJ: Differential effects of stress on in vivo dopamine release in striatum, nucleus accumbens and medial prefrontal cortex. J Neurochem 1989;52:1655-1658.
50. 1 receptor activation reduced stress gastric lesions gastric acid secretion. Int J Exp Clin Gastroenterol 1991;1:55-60.
51. Blondeau JM, Aoki FY, Glavin GB: Stress-induced reactivation of latent herpes simplex virus infection in rat lumbar dorsal root ganglia. J Psychosom Res 1993:37:843-849.
52. Besedovsky H, Del Rey A, Sorkin E, Dinarello CA: Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986;23:3652-3654.
53. Zorrilla EP, Luborsky L, McKay JR, Rosenthal R, Houldin A, Tax A, McCorkle R, Seligman R, Phimidt KCS: The relationship of depression and stressors to immunological assays: a meta analytic review. Brain Behav Immun 2001;15:199-226.
54. Haddad JJ, Saade NE, Safieh-Garabedian B: Cytokines and neuro-immune-endocrine interaction: a role for the hypothalamic-pituitary- adrenal revolving axis. J Neuroimmunol 2002;133:1-19.
55. Palermo-Neto J, de Oliveira Massoco C, Robespierre de Souza W: Effects of physical and psychological stressors on behavior, macrophage activity, and Ehrlich tumor growth. Brain Behav Immun 2003;17:43-54.
56. Alves GJ, Vismari L, Florio JC, Palermo-Neto J: Cohabitation with a sick cage mate: effects on noradrenaline turnover and neutrophil activity. Neurosci Res 2006;56:172-179.
57. Chamandari E, Tsigos C, Chrousos G: Endocrinology of the stress response. Annu Rev Physiol 2005;67:259-284.
58. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O'Shea JJ, Chrousos GP, Bornstein SR: Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 2002;16:61-71.
59. Song C, Earley B, Leonard BE: Behavioral, neurochemical, and immunological responses to CRF administration. Is CRF a mediator of stress? Ann NY Acad Sci 1995;771:55-72.
60. Békési G, Rácz K, Hrabák A, Kakucs R, Várbíró S, Magyar Z, Fehér J, Dinya E, Pázmány T, Paku S, Székács B: Systematic investigation of different steroid precursors with respect to their effect on superoxide anion production by human neutrophil granulocytes. Horm Metab Res 2004;36:155-163.
61. Connor TJ, McNamara MG, Finn D, Currid A, O'Malley M, Redmond AM, Kelly JP, Leonard BE: Acute 3,4-methylenedioxymethamphetamine (MDMA) administration produces a rapid and sustained suppression of immune function in the rat. Immunopharmacology 1998;38:253-260.
62. House RV, Thomas PT, Bhargava HN: Selective modulation of immune function resulting from in vitro exposure to methylenedioxymethamphetamine (Ecstasy). Toxicology 1995;96:59-69.
63. Elenkov IJ, Chrousos GP: Stress system - organization, physiology and immunoregulation. Neuroimmunomodulation 2006;13:257-267.
64. Engler H, Dawils L, Hoves S, Kurth S, Stevenson JR, Schauenstein K, Stefanski V: Effects of social stress on blood leukocyte distribution: the role of α- and β-adrenergic mechanisms. J. Neuroimmunol 2004;156:153-162.
65. Ottaway CA, Husband AJ: The influence of neuroendocrine pathways on lymphocyte migration. Immunol Today 1994;15:511-517.
66. Dhabhar FS, Miller AH, McEwen BS, Spencer RL: Stress-induced changes in blood leukocyte distribution. Role of adrenal steroid hormones. J Immunol 1996;157:1638-1644.
67. Sendo F, Kato T, Yazawa H: Modulation of neutrophil apoptosis by psychological stress and glucocorticoid. Int J Immunopharmacol 1997;19:511-516.
68. Liles WC, Dale DC, Klebanoff SJ: Glucocorticoids inhibit apoptosis of human neutrophils. Blood 1995;86:3181-3188.
69. Meagher LC, Cousin JM, Seckl JR, Haslett C: Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 1996;156:4422-4428.
70. Miller AH, Spencer RL, Hassett J, Kim C, Rhee R, Ciurea D, Dhabhar F, McEwen B, Stein M: Effects of selective type I and II adrenal steroid agonists on immune cell distribution. Endocrinology 1994;135:1934-1944.
71. Simon HU: Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev 2003;193:101-110.
72. Madden KS, Sanders VM, Felten DL: Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 1995;35:417-448.
73. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES: The sympathetic nerve - an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 2000;52:595-638.
74. Nance DM, Sanders VM: Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 2007;21:736-745.
75. Kaufman MJ, Siegel AJ, Mendelson JH, Rose SL, Kukes TJ, Sholar MB, Lukas SE, Renshaw PF: Cocaine administration induces human splenic constriction and altered hematologic parameters. J Appl Physiol 1998;85:1877-1883.
76. Ojiri Y, Noguchi K, Chibana T, Sakanashi M: Effects of adrenergic stimulants on the splenic diameter, hemoglobin content and hematocrit in anesthetized dogs: determination of the adrenoceptor subtype responsible for changes in the splenic diameter. Acta Physiol Scand 1993;149:31-39.
77. 2 reduce requirement for CBF in conscious dogs. Am J Physiol 1995;269:491-503.
78. Shannon RP, Manders WT, Shen YT: Role of blood doping in the coronary vasoconstrictor response to cocaine. Circulation 1995;92:96-105.
79. Liechti ME, Vollenweider FX: Which neuroreceptors mediate the subjective effects of MDMA in humans? A summary of mechanistic studies. Hum Psychopharmacol 2001;16:589-598.
80. Marazziti D, Rossi A, Giannacini G, Baroni S, Lucacchini A, Cassano GB: Presence and characterization of the serotonin transporter in human resting lymphocytes. Neuropsychopharmacology 1998;19:154-159.
81. Mössner R, Lesch KP: Role of serotonin in the immune system and neuroimmune interactions. Brain Behav Immun 1998;12:249-271.
82. Mizruchin A, Gold I, Krasnov I, Livshitz G, Shahin R, Kook AI: Comparison of the effect of dopaminergic and serotoninergic activity in the CNS on the activity of the immune system. J Neuroimmunol 1999;101:201-204.
83. Basu S, Dasgupta PS: Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol 2000;102:113-124.
84. Ezekowitz RAB, Hoffmann J: Innate immunity: The blossoming of innate immunity. Curr Opin Immunol 1998;10:9-53.